Seeking Alpha

Ocuphire Pharma and Viatris Announce FDA Approval of RYZUMVI™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis ...

FARMINGTON HILLS, Mich., and PITTSBURGH, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and ...
KOIN 6

RYZUMVI Expected to be Commercially Available in the U.S. in the First Half of 2024

FARMINGTON HILLS, Mich., and PITTSBURGH, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and ...
Business Wire

OSRX Expands Ophthalmic Solutions with New Medications and Post-Op Kits to Patients’ Doors

The top innovator in quality compounded solutions and post-operative eye care launches a game changer. MISSOULA, Mont.--(BUSINESS WIRE)--OSRX, a leader in ophthalmic compounding, introduces new ...
clickondetroit.com

FDA says this popular decongestant doesn’t actually work: What to know about phenylephrine

FILE - Sudafed and other common nasal decongestants containing pseudoephedrine are on display behind the counter at Hospital Discount Pharmacy in Edmond, Okla., Jan. 11, 2005. The leading decongestant ...
Medscape

Patch Testing Can Help Diagnose Allergies From Eye Drops

"Clinicians should be observant on the risk of development of allergic contact dermatitis, which may lead to various symptoms such as erythema, edema, dermatitis, pruritus, epiphora, and ...
Seeking Alpha

Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis ...

PITTSBURGH, and FARMINGTON HILLS, Mich., Sept. 27, 2023 /PRNewswire/ -- Viatris Inc. (VTRS), a global healthcare company, and Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic ...